U.S. RESEARCH ROUNDUP-Esperion Therapeutics, Office Properties Income Trust, Radius Global Infrastructure

ATI

07/03/2023 07:15

March 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Esperion Therapeutics, Office Properties Income Trust and Radius Global
Infrastructure, on Tuesday.

    HIGHLIGHTS
                 * Esperion Therapeutics Inc  ESPR.O : Credit Suisse cuts to neutral from underperform 
 
                 * Office Properties Income Trust  OPI.O : RBC cuts to underperform from sector perform 
 
                 * Radius Global Infrastructure Inc  RADI.O : Jefferies cuts to hold from buy 
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are
in alphabetical order.

                 * Aflac Inc  AFL.N : Citigroup raises price target to $73 from $71 
 
                 * Air Products and Chemicals Inc  APD.N : Evercore ISI raises target to $305 from $295 
 
                 * Allakos Inc  ALLK.O : Jefferies cuts target price to $6 from $7 
 
                 * Alphatec Holdings Inc  ATEC.O : Jefferies raises target price to $20 from $14 
 
                 * American Tower Corp  AMT.N : Jefferies raises target price to $244 from $239 
 
                 * Anywhere Real Estate Inc  HOUS.N : JP Morgan cuts target price to $7 from $11 
 
                 * Array Technologies Inc  ARRY.O : Piper Sandler cuts target price to $26 from $28 
 
                 * Asana Inc  ASAN.N : JP Morgan cuts target price to $15 from $18 
 
                 * Ati Inc  ATI.N : Keybanc raises target price to $47 from $45 
 
                 * Bluebird Bio Inc  BLUE.O : Baird initiates coverage with outperform rating and $10 PT
 
                 * Bridgebio pharma Inc  BBIO.O : JP Morgan raises target price to $23 from $18 
 
                 * Bridgebio pharma Inc  BBIO.O : Raymond James raises target price to $29 from $17 
 
                 * Cara Therapeutics Inc  CARA.O : Jefferies cuts target price to $18 from $20 
 
                 * Cara Therapeutics Inc  CARA.O : JP Morgan cuts target price to $16 from $19 
 
                 * Cara Therapeutics Inc  CARA.O : Piper Sandler cuts target price to $13 from $25 
 
                 * Ciena Corp  CIEN.N : Evercore ISI raises target price to $57 from $55 
 
                 * Ciena Corp  CIEN.N : JP Morgan raises target price to $66 from $65 
 
                 * Ciena Corp  CIEN.N : Raymond James raises target price to $58 from $57 
 
                 * Cogent Communications Holdings Inc  CCOI.O : RBC raises target price to $69 from $61 
 
                 * Cti Biopharma Corp  CTIC.O : BTIG cuts target price to $9 from $10 
 
                 * Cymabay Therapeutics Inc  CBAY.O : Oppenheimer raises target price to $12 from $10 
 
                 * Cytek Biosciences Inc  CTKB.O : Piper Sandler cuts target price to $15 from $18 
 
                 * Davita Inc  DVA.N : Bernstein reinitiates coverage with market perform rating; $88 PT
 
                 * Docusign Inc  DOCU.O : Jefferies raises target price to $80 from $70 
 
                 * Energy Transfer LP  ET.N : JP Morgan raises target price to $18 from $17 
 
                 * Equitable Holdings Inc  EQH.N : Citigroup raises price target to $40 from $37 
 
                 * Esperion Therapeutics Inc  ESPR.O : Credit Suisse cuts to neutral from underperform 
 
                 * Esperion Therapeutics Inc  ESPR.O : Credit Suisse raises target price to $7 from $6.5 
 
                 * Guidewire Software Inc  GWRE.N : JP Morgan raises target price to $83 from $78 
 
                 * Interactive Brokers Group Inc  IBKR.O : Jefferies raises target price to $104 from $91 
 
                 * ITT Inc  ITT.N : Stifel raises target price to $107 from $100 
 
                 * Lincoln National Corp  LNC.N : CFRA cuts target price by $4 to $33 
 
                 * Lincoln National Corp  LNC.N : Citigroup raises price target to $33 from $31 
 
                 * Linde Plc  LIN.N : Evercore ISI raises target price to $375 from $355 
 
                 * Merck & Co Inc  MRK.N : Credit Suisse raises target price to $126 from $125 
 
                 * Mongodb Inc  MDB.O : Citigroup cuts price target to $295 from $300 
 
                 * Office Properties Income Trust  OPI.O : RBC cuts to underperform from sector perform 
 
                 * Office Properties Income Trust  OPI.O : RBC cuts target price to $14 from $16 
 
                 * Passage Bio Inc  PASG.O : BTIG cuts target price to $5 from $9 
 
                 * Permian Resources Corp  PR.N : RBC raises target price to $14 from $13 
 
                 * Qualtrics International Inc  XM.O : Piper Sandler raises target price to $18.15 from $16 
 
                 * Quanterix Corp  QTRX.O : Canaccord Genuity raises target price to $13 from $12 
 
                 * Radius Global Infrastructure Inc  RADI.O : Jefferies cuts to hold from buy 
 
                 * Radius Global Infrastructure Inc  RADI.O : Jefferies raises target price to $15 from $14 
 
                 * Rallybio Corp  RLYB.O : Jefferies cuts target price to $16 from $19 
 
                 * Riley Exploration Permian Inc  REPX.A : Truist Securities raises target to $43 from $39 
 
                 * Rxsight Inc  RXST.O : JP Morgan cuts target price to $20 from $22 
 
                 * Smartsheet Inc  SMAR.N : Jefferies raises target price to $55 from $50 
 
                 * Springworks Therapeutics Inc  SWTX.O : JP Morgan raises target price to $57 from $53 
 
                 * Stoke Therapeutics Inc  STOK.O : Credit Suisse cuts target price to $28 from $32 
 
                 * Sunnova Energy International Inc  NOVA.N : Piper Sandler raises target to $27 from $26 
 
                 * Syndax Pharmaceuticals Inc  SNDX.O : JP Morgan cuts target price to $36 from $41 
 
                 * Tcr2 Therapeutics Inc  TCRR.O : Wedbush cuts target price to $2.18 from $4 
 
                 * Thredup Inc  TDUP.O : Jefferies cuts target price to $4 from $5 
 
                 * Tripadvisor Inc  TRIP.O : D.A. Davidson cuts target price to $28 from $30 
 
                 * Virgin Galactic Holdings Inc  SPCE.N : Wells Fargo cuts target price to $2.5 from $3 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))